Orlando, Florida-based Lensar designed the Ally adaptive cataract treatment system to enable cataract surgeons to complete the femtosecond-laser-assisted cataract (FLACS) procedure seamlessly in a single, sterile environment.
According to a news release, the company intends to deliver the first Ally systems to surgeons in the third quarter of this year by way of a controlled and targeted initial launch, which will be followed by wide availability of the system to cataract surgeons in 2023.
Lensar said in the release that Ally has a small footprint with enhanced ergonomics, providing surgeons with a unique opportunity to improve efficiencies in any operating room or an in-office surgical suite. Ally represents the first cataract surgery platform to use adaptive intelligence to automatically determine cataract density, optimize fr…